Publications
75 publications
Funding
4 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPIR01CA288880-03Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal CancerNCI · 2024–2029 · via NIH RePORTER
- PIU01CA271287-04Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancerNCI · 2022–2027 · via NIH RePORTER
Completed grants (2)
- MPIU01CA238444-05Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)NCI · 2020–2025 · via NIH RePORTER
- PIR21CA252519-02Neoadjuvant PD-1 blockade in mismatch repair deficient rectal cancerNCI · 2021–2024 · via NIH RePORTER